Visalytics
Visalytics
approved EB-2 (NIW)

Advanced Data Science Consultant

Chemical Engineering · India · 2025-01-16

Processing Time
45 days
Decision Date
2025-01-16
Location
New Jersey
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on developing advanced machine learning, artificial intelligence, and language modeling frameworks by integrating data-driven methods with domain knowledge. This work aims to address key challenges in drug development and healthcare, specifically focusing on accelerating drug discovery, optimizing clinical trials, and enhancing manufacturing efficiency.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on AI and machine learning for drug discovery was found to have clear substantial merit and national importance for U.S. healthcare and scientific progress.

2 Well-positioned to Advance the Endeavor Met

The petitioner's extensive publication record, citation count, and peer review experience demonstrate they are well-positioned to advance the proposed work.

3 Waiver Benefit Met

The interest and backing from major funding bodies like the NSF confirm that it is in the national interest to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's 13 peer-reviewed journal articles and 14 abstracts which garnered 239 citations, demonstrating significant influence in the field. Additionally, the petitioner conducted 38 peer reviews for highly ranked journals and secured funding from the U.S. National Science Foundation and the Lilly Research Award Program. These achievements satisfied all three prongs of the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Government Alignment

Similar Cases

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
Georgia 67 days 2025-05-14
The petitioner proposes to develop advanced artificial intelligence models and algorithms to improve early disease diagnosis and predict patient responses to new drugs and combination therapies. This work focuses on enhancing diagnostic precision and treatment effectiveness to accelerate drug discovery and optimize healthcare outcomes. The endeavor specifically aims to benefit vulnerable populations, including infants and the elderly, through optimized medical interventions.
View Case

Chief Executive Officer (CEO)

Artificial Intelligence · Syria

WeGreened EB-2 (NIW) approved
200 days 2025-06-25
The petitioner proposes to lead scientific initiatives building machine learning models that accelerate the drug discovery process, specifically focusing on simulating molecular interactions to design personalized cancer treatments. Her work aims to address bottlenecks in drug development by blending multi-omics data with predictive AI systems to reduce costs and increase precision.
View Case

Professor

Biotechnology · Ethiopia

WeGreened EB-2 (NIW) approved
87 days 2025-01-13
The petitioner proposes to continue research integrating advanced computational techniques and artificial intelligence to decode complex biological mechanisms and identify new drug targets. This work focuses on streamlining drug discovery processes and improving treatment efficacy for complex diseases such as Acute Myeloid Leukemia (AML).
View Case

Research Assistant

Artificial Intelligence · Bangladesh

WeGreened EB-2 (NIW) approved
South Carolina 344 days 2025-06-03
The petitioner proposes to develop advanced AI models, specifically graph neural networks and deep learning architectures, for predicting drug-target interactions and optimizing drug compounds. This work aims to revolutionize drug discovery, accelerate molecular simulations, and facilitate the identification of crystal structures for pharmaceutical and optoelectronic applications.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Engineering cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-16.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 45 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist